Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Palisade Bio Q3 EPS $(0.08) Down From $0.42 YoY

Palisade Bio Q3 EPS $(0.08) Down From $0.42 YoY

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.

News
Tech

Apple Chooses Sam Altman-Led OpenAI To Integrate ChatGPT Into iPhone, Deal Almost Done: Report

By Ananya Gairola

May 10, 9:56 PM

Apple is nearing a deal to integrate OpenAI's technology into the iPhone, aiming to enhance iOS 18 with new artificial intelligence features.

AAPL

News

Chicago Fed President Evans Says There’s Good Consensus The Policy Rate Should Continue To Go Up; At Some Point We Will Have To Slow Rate Hikes A Little Bit

By Benzinga Newsdesk

September 28, 4:05 PM

- Reuters

SPY

Engineering Firm KBR Signs Lithium Tech Agreement With GeoLith: Details

By Shivani Kumaresan

April 15, 7:55 AM

KBR teams up with GeoLith SAS for exclusive access to cutting-edge Direct Lithium Extraction technology, Li-Capt. With KBR as the global licensor, the adaptable Li-Capt technology promises pure lithium concentrate from diverse brine sources.

KBR